-
1Report
المؤلفون: Ministry of Health, France, CH du Puy en Velay, Hôpital Emile Roux, University Hospital, Toulouse, Centre hospitalier de Chambéry, Calydial, Hôpital Edouard Herriot, Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex, Hôpital Lapeyronie, Centre de dialyse d'Alès, University Hospital of Saint-Etienne, Centre hospitalier de Perpignan, Centre de néphrologie Polyclinique Médipôle Saint-Roch, Rue Ambroise Croizat, CHU Hôpital Maison Blanche, 45 Rue Cognacq-Jay 51092 REIMS Cedex
المصدر: Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients: a mulTi-centre, Randomized, Single Blind, Parallel Group studY (ETERNITY)
Aniort J, Piraud A, Adda M, Perreira B, Bouiller M, Fourcade J, Guerraoui A, Kalbacher E, Krumel T, Moragues HL, Thibaudin D, Vela CG, Vernin G, Weclawiak H, Bernard L, Heng AE, Souweine B. Evaluation of the efficacy of an interdialytic "ethanol 40% v/v - enoxaparin 1000 U/mL" lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients: a multi-centre, randomized, single blind, parallel group study. BMC Nephrol. 2019 Apr 30;20(1):149. doi: 10.1186/s12882-019-1338-6.